Prelude Capital Management, LLC Axsome Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.23 Billion
- Q1 2025
A detailed history of Prelude Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 7,200 shares of AXSM stock, worth $808,920. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,200Holding current value
$808,920% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
410Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$436 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$371 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$328 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$190 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$110 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.82B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...